Position doing the winning: current wins credited to a standing already held, with more arriving over it
The model's full reasoning — Q3 2023 call → NOThe question asks whether management explains current business wins as flowing from a standing the company already holds, and whether more business is arriving over that same standing without a proportional new push. Looking at the transcript, management discusses the U.S. launch, market share, and the company's position. They mention being "third to market" and having "low-single digit market share" but seeing "up to 10% market share" in a select national retailer. They attribute this to being "on a level playing field" and having "good recommendation coming from the pharmacy." The key question is whether management credits an already-held standing (like an approval, distribution network, or product position) as the cause of current wins, and whether more business is arriving over that same standing. Management mentions: - The vaccine is "the only protein-based non-mRNA option" - this is a product position - They have "secured broad access" through contracts with major retailers - They have "over 14,000 retail outlets" - a distribution footprint But are current wins attributed to this standing? They say they're seeing "low-single digit market share" and that it's "too early to assess our full 2023 potential." They attribute early indicators to being "on a level playing field" and pharmacy recommendations. The wins described are modest - low-single digit share, up to 10% in one retailer. The standing they have (distribution, product position) is real, but the wins are described as early and uncertain. They say "we believe that it is too early to assess our full 2023 potential." For continuation, they mention "we anticipate market share improvement over the course of this season based upon both consumer and HCP demand" - but this seems more like a hope/projection than something already flowing. The company is also describing significant challenges - "slower season start," "distribution challenges," "vaccine fatigue." They're not really describing a standing that is generating wins; they're describing an early launch with uncertain uptake. The wins they do have (10% in one retailer) are attributed to being "on a level playing field" and pharmacy recommendations - which is more about execution in the moment than a durable standing.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| ACGL | Arch Capital Group Ltd. | Q4 2023 | 2024-02-15 | B+ |
| CHT | Chunghwa Telecom Co., Ltd. | Q4 2023 | 2024-01-30 | C |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| SPIR | Spire Global, Inc. | Q1 2023 | 2023-05-10 | B |
| FTHM | Fathom Holdings, Inc. | Q1 2023 | 2023-05-10 | C |
| BXSL | Blackstone Secured Lending Fund | Q1 2023 | 2023-05-10 | A |
| POOL | Pool Corporation | Q4 2022 | 2023-02-16 | C+ |
| EXFY | Expensify, Inc. | Q2 2022 | 2022-08-12 | D |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| WMB | The Williams Companies, Inc. | Q3 2021 | 2021-11-02 | B |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| ROK | Rockwell Automation, Inc. | Q4 2017 | 2017-11-08 | C |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| LEA | Lear Corporation | Q2 2017 | 2017-07-26 | B+ |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
EXFY · Q2 2022 → YESThe question is about whether management credits a standing the company already holds as the reason they're currently winning business, and that more is arriving over that same standing without a new ...YES The transcript shows management crediting their pre-existing bottom-up adoption model and differentiated platform position (already in place since day one, with SMB focus and unique acquisition mechanics) as the operative cause of current wins. This is evident in statements like the model being "overwhelmingly driving the success of our business" and competitors routing customers to them due to the same standing. Further business is conveyed as already arriving through the same position, with trends continuing and the best quarter ever achieved on that foundation, even as they note additional investments in sales and conferences.
FTHM · Q1 2023 → YESThe question is about whether management credits a standing the company already holds as the reason they're currently winning business, and if more business is arriving over that same standing without...YES The transcript shows management crediting the company's pre-existing low-cost flat-fee model, owned technology, and culture-driven retention as the durable standing already in place that is generating current wins (market share gains, 18% agent growth, 60% of March referrals, and transaction resilience vs. peers). They describe these as flowing directly from that standing rather than fresh effort, while conveying continuation through the referral program's ongoing positive impact and the model's ability to draw more agents without proportional new marketing push.
ORAN · Q2 2018 → YESThe question is about whether management credits a standing the company already holds as the reason they're currently winning business, and that more is arriving over that same standing without a new ...YES The transcript shows management repeatedly tying current wins (net adds, ARPU growth, EBITDA expansion) directly to a pre-existing durable position: the #1 convergent operator status already achieved through prior leadership in fixed/mobile networks and fiber rollout, plus the installed base of 10.